Showing 1461-1470 of 1655 results for "".
- EssilorLuxottica Closes Acquisition of Walman Opticalhttps://modernod.com/news/essilorluxottica-closes-acquisition-of-walman-optical/2480668/EssilorLuxottica announces today the closing of its acquisition of U.S.-based lab network Walman Optical, a leading lab partner to vision care practices around the country. First announced in March 2021, the acquisition will draw on EssilorLuxottica’s focus on product and service innovation
- Prevent Blindness to Hold 17th Annual “Eyes on Capitol Hill” Advocacy Eventhttps://modernod.com/news/prevent-blindness-to-hold-17th-annual-eyes-on-capitol-hill-advocacy-event/2480666/Prevent Blindness will be holding its 17th annual Eyes on Capitol Hill advocacy day as a virtual event on March 1-2, 2022. Continuing its mission as a patient advocacy group, Prevent Blindness created the Eyes on Capitol Hill program specifically to provide patients, caregivers, al
- Aerie Pharmaceuticals Appoints Gary Sternberg, MD, MBA, as Chief Medical Officerhttps://modernod.com/news/aerie-pharmaceuticals-appoints-gary-sternberg-md-mba-as-chief-medical-officer/2480665/Aerie Pharmaceuticals announced that Gary Sternberg, MD, MBA, will join the company as Chief Medical Officer (CMO), effective March 1, 2022. He will report to Raj Kannan, Chief Executive Officer of Aerie Pharmaceuticals and become a member of the Aerie Executive Comm
- Panelists Named for “Making Contact Lens Compliance Stick” Eventshttps://modernod.com/news/panelists-named-for-making-contact-lens-compliance-stick-events/2480644/Four highly regarded optometrists have been named as panelists for a pair of Contact Lens Institute online learning events scheduled for March 3. Drs. Chris Lievens, Mark Schaeffer, Bridgitte Shen Lee, and Jason Tu will headline “
- EyePoint Pharmaceuticals Receives Preliminary Extension to Pass-Through Payment Status for Dexycuhttps://modernod.com/news/eyepoint-pharmaceuticals-receives-preliminary-extension-to-pass-through-payment-status-for-dexycu/2479385/EyePoint Pharmaceuticals announced today that the company expects to receive a 9-month extension on Dexycu’s pass-through payment status, which otherwise would expire on March 31, 2022. On July 19, 2021, CMS released its 2022 draft Hospital Outpatient Prospective
- Nicox to Receive $2 Million from Ocumension as Milestone Payment Under Zerviate Agreementhttps://modernod.com/news/nicox-to-receive-2-million-from-ocumension-as-milestone-payment-under-zerviate-agreement/2479339/Nicox announced that it has amended its March 2019 license agreement with Ocumension Therapeutics, under which Ocumension has exclusive rights to develop and commercialize Zerviate (cetirizine ophthalmic solution), 0.24% in the Chinese and the majority of South East Asian markets. Under the amend
- Nicox’s Licensee Bausch + Lomb Launches Vyzulta in Taiwan and Receives Approval in Qatarhttps://modernod.com/news/nicoxs-licensee-bausch-lomb-launches-vyzulta-in-taiwan-and-receives-approval-in-qatar/2479163/Nicox SA announced that its exclusive global licensee Bausch + Lomb has launched Vyzulta (latanoprostene bunod ophthalmic solution) 0.024% in Taiwan. Regulatory approval in Taiwan was obtained in March 2020. Vyzulta has also recently received approval in Qatar. In addition to Taiwan, Vyzul
- Avellino Exceeds 1 Million COVID-19 Tests in 2020 and Welcomes New Executive Team Hires In 2021https://modernod.com/news/avellino-exceeds-1-million-covid-19-tests-in-2020-and-welcomes-new-executive-team-hires-in-2021/2478756/Avellino Lab USA announced that the company performed over 1 million AvellinoCoV2 COVID-19 tests since March 2020, and has further expanded the company’s executive team to drive additional development and commercial growth in 2021. Chief Scientific Officer, Nazneen Aziz, PhD, and Global Head of S
- Demand, Pay for Travel ICU Nurses Soar as Hospitals Face Staff Crunch Due to COVID-19https://modernod.com/news/demand-pay-for-travel-icu-nurses-soar-as-hospitals-face-staff-crunch-due-to-covid-19/2478681/Staffing crunches caused by COVID-19 created a massive 305% increase in demand for intensive care unit travel nurses from March to November, according to a new report, as
- Moran Eye Center Lab Produces World’s First ‘Pathoconnectome’https://modernod.com/news/moran-eye-center-lab-produces-worlds-first-pathoconnectome/2478338/Scientists from the John A. Moran Eye Center at the University of Utah have achieved another first in the field of connectomics, which studies the synaptic connections between neurons. Moran’s Marclab for Connectomics was the first to complete a map of the circuitry of the retina, or conne